0000025743-23-000001.txt : 20230711
0000025743-23-000001.hdr.sgml : 20230711
20230710174947
ACCESSION NUMBER: 0000025743-23-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230711
DATE AS OF CHANGE: 20230710
EFFECTIVENESS DATE: 20230711
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TherapeuticsMD, Inc.
CENTRAL INDEX KEY: 0000025743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870233535
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-486406
FILM NUMBER: 231080732
BUSINESS ADDRESS:
STREET 1: 951 YAMATO ROAD, SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
BUSINESS PHONE: 561-961-1900
MAIL ADDRESS:
STREET 1: 951 YAMATO ROAD, SUITE 220
CITY: BOCA RATON
STATE: FL
ZIP: 33431
FORMER COMPANY:
FORMER CONFORMED NAME: AMHN, Inc.
DATE OF NAME CHANGE: 20090930
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF ENTERPRISES INC
DATE OF NAME CHANGE: 19970915
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF OIL CO
DATE OF NAME CHANGE: 19920703
D
1
primary_doc.xml
X0708
D
LIVE
0000025743
TherapeuticsMD, Inc.
951 YAMATO ROAD, SUITE 220
BOCA RATON
FL
FLORIDA
33431
561-961-1900
NEVADA
AMHN, Inc.
CROFF ENTERPRISES INC
CROFF OIL CO
Corporation
true
Michael
C.
Donegan
951 Yamato Road
Suite 220
Boca Raton
FL
FLORIDA
33431
Executive Officer
Tommy
G.
Thompson
951 Yamato Road
Suite 220
Boca Raton
FL
FLORIDA
33431
Director
Gail
Naughton
951 Yamato Road
Suite 220
Boca Raton
FL
FLORIDA
33431
Director
Cooper
C.
Collins
951 Yamato Road
Suite 220
Boca Raton
FL
FLORIDA
33431
Director
Marlan
Walker
951 Yamato Road
Suite 220
Boca Raton
FL
FLORIDA
33431
Executive Officer
Justin
Roberts
951 Yamato Road
Suite 220
Boca Raton
FL
FLORIDA
33431
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2023-06-29
false
true
false
0
5000000
1149998
3850002
Pursuant to a Subscription Agreement with Rubric Capital Management LP, the Company may sell, at the Company's election, up to an aggregate of 5,000,000 shares of the Company's common stock, at an aggregate purchase price of up to $5,000,000.
false
2
0
0
0
false
TherapeuticsMD, Inc.
/s/ Marlan Walker
Marlan Walker
Chief Executive Officer
2023-07-10